← FDA DRUG APPROVALS

FDA ANDA · ANDA206914

OXYCODONE HYDROCHLORIDE

Sponsor: PHARM ASSOC

APPLICATION
ANDA206914
TYPE
ANDA
ORIGINAL APPROVAL
2019-02-01
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

OXYCODONE HYDROCHLORIDEPrescription
OXYCODONE HYDROCHLORIDE 5MG/5ML · SOLUTION · ORAL

Approval history

2026-06-18REMS · Supplement 15AP
2025-12-22Labeling · Supplement 13 · standardAP
2025-12-09Labeling · Supplement 10 · standardAP
2025-12-09Labeling · Supplement 6 · standardAP
2025-12-09Labeling · Supplement 4 · standardAP
2025-12-09Labeling · Supplement 11 · standardAP
2025-12-09Labeling · Supplement 7 · standardAP
2024-10-31REMS · Supplement 9AP
2019-02-01UNKNOWN · Original · standardREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →